IL-1, IL-1R and TNFα gene polymorphisms in Iranian patients with multiple sclerosis

Iranian Journal of Allergy, Asthma and Immunology

Volumn 7, Issue 1, 2008, Pages 37-40

  Sarial, Sheila ^a,b   Shokrgozar, Mohammad Ali ^a   Amirzargar, Aliakbar ^c   Shokri, Fazel ^a   Radfar, Jalaledin ^a   Zohrevand, Pantea ^d   Arjang, Zohreh ^a   Sahraian, Mohammad Ali ^d   Lotfi, Jamshid ^d  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Iranian Diabetes Society   (Iran)

Author keywords

Cytokines; Gene polymorphism; IL 1; Multiple sclerosis; Single nucleotide polymorphism; TNF

Indexed keywords

DNA; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; NUCLEOTIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE PREDISPOSITION; DNA DETERMINATION; DNA EXTRACTION; DNA POLYMORPHISM; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION; POPULATION; RECURRENT DISEASE;

ADULT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-1; IRAN; MALE; MULTIPLE SCLEROSIS; POLYMORPHISM, GENETIC; RECEPTORS, INTERLEUKIN-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 42149187660     PISSN: 17351502     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med 2000; 343(13):938-52.
2. Lassmann H, Mechanisms of multiple sclerosis, J. Drug Delivery Today: Disease mechanisms/Nervous system 2005; 2(4): 448-52.
3. Charcot J. Histologie de la sclérose en plaque. Gazette Des Hôpitaux 1868; 41: 554-66.
4. Imitola J, Chitnis T, Khour S. Cytokines in multiple sclerosis: from bench to bedside. Pharmacol Ther 2005; 106(2):163-77.
5. Bidwell J, Keen L, Gallagher G, Kimberley R, Huizinga T, McDermott MF, et al. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun 1999; 1(1):3-19.
6. Bidwell J, Keen L, Gallagher G, Kimberley R, Huizinga T, McDermott MF, et al. Cytokine gene polymorphism in human disease: on-line databases, Supplement 1. Genes Immun 2001; 2(2):61-70.
7. Dyment DA, Ebers GC, Sadovnick AD. Genetics of multiple sclerosis. Lancet Neurol 2004; 3(2):104-10.
8. Bidwell JL, Wood NAP, Morse HR, Olomolaiye OO, Laundy GJ. Human cytokine gene nucleotide sequence alignments. Eur J Immunogenet 1998; 25:83-266.
9. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. J Nucleic Acids Res 1988; 16(3):1215.
10. Park JY, Park MH, Park H, Ha J, Kim SJ, Ahn C. TNF-alpha and TGF-beta1 gene polymorphisms and renal allograft rejection in Koreans. Tissue Antigens 2004; 64(6):660-6.
11. Mann CL, Davies MB, Stevenson VL, Leary SM, Boggild MD, Ko Ko C, et al., Interleukin 1 genotypes in multiple sclerosis and relationship to disease severity. J Neuroimmunol 2002; 129(1-2):197-204.
12. Feakes R, Sawcer S, Broadley S, Coraddu F, Roxburgh R, Gray J, et al. Interleukin 1 receptor antagonist (IL-1ra) in multiple sclerosis. J Neuroimmunol 2000; 105(1):96-101.
13. Kantarci OH, Atkinson EJ, Hebrink DD, McMurray CT, Weinshenker BG. Association of two variants in IL-1beta and IL-1 receptor antagonist genes with multiple sclerosis. J Neuroimmunol 2000; 106(1-2):220-7.
14. Sciacca FL, Ferri C, Vandenbroek K, Veglia F, Gobbi C, Martinelli F, et al. Prevalence of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patients. Neurology 1999; 52(9):1896-8.
15. Niino M, Kikuchi S, Fukazawa T, Yabe I, Sasaki H, Tashiro K. Genetic polymorphisms of IL-1beta and IL-1 receptor antagonist in association with multiple sclerosis in Japanese patients. J Neuroimmunol 2001; 118(2):295-9.
16. Maurer M, Kruse N, Giess R, Kyriallis K, Toyka KV, Rieckmann P. Gene polymorphism at position -308 of the tumor necrosis factor alpha promotor is not associated with disease progression in multiple sclerosis patients. J Neurol 1999; 246(10):949-54.